A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Cancers | Free Full-Text | Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study
Cancers | Free Full-Text | Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Long-Term Follow-up of Survival in Hodgkin's Lymphoma | NEJM
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - ScienceDirect
Kaplan-Meier curves for (A) event-free survival and (B) | Open-i
Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching | PLOS ONE
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Event-free survival and overall survival (A) Event-free survival for... | Download Scientific Diagram
Cureus | Does Timing of Completion Radical Cholecystectomy Determine the Survival Outcome in Incidental Carcinoma Gallbladder: A Single-Center Retrospective Analysis | Article
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433 | Haematologica
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children | NEJM
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Kaplan-Meier plot of event-free survival (EFS) and overall survival... | Download Scientific Diagram
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer
Event-free survival at 24 months is a robust surrogate endpoint for long-term survival in pediatric, adolescent, and adult T cell lymphoblastic lymphoma | SpringerLink
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
When Overall Survival Fails to Confirm Event-Free Survival, Should the Latter Be Used to Set the Standard of Care? | Journal of Clinical Oncology
